The 2010 Merger Guidelines and the “Litigation Mulliganâ€Â: Better Economics but Not (Necessarily) More Clarity Before the Agencies and the Courts

Emerging Competition Issues Involving Follow-On Biologics

Tucker, Darren S., (2014)

REMS : The Next Pharmaceutical Enforcement Priority?

Tucker, Darren S., (2014)

Introduction to Harberger's <em>Monopoly and Resource Allocation</em>--The Pioneering Article on Deadweight Loss and Empirical Measurement of the Social Costs of Monopoly

Wellford, Hill, (2009)